Related Experiment Video
Updated: May 22, 2026
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Analysis of influencing factors and structural changes in hospitalization expenses for heart failure patients under
Danqi Huang1, Hongda Gao1, He Chen2
1School of Information and Management, Guangxi Medical University, Nanning, China.
Insights
The Diagnosis-Related Group (DRG) payment system reform effectively reduced hospitalization expenses for heart failure (HF) patients. Key factors influencing costs include patient demographics, length of stay, and specific fees like diagnosis and drug costs.
Area of Science:
- Health Economics
- Healthcare Management
- Medical Informatics
Background:
- The implementation of the Diagnosis-Related Group (DRG) payment system aims to reform healthcare financing and control medical costs.
- Heart failure (HF) represents a significant healthcare burden, necessitating an understanding of its associated hospitalization expenses.
Purpose of the Study:
- To analyze the influencing factors and structural changes in hospitalization expenses for heart failure (HF) patients under the DRG payment system.
- To provide a scientific basis for hospitals to manage and reduce HF patient hospitalization costs.
Main Methods:
- Analysis of 4,791 hospitalized HF patients' data from January 2015 to July 2025.
- Utilized univariate analysis, multiple linear regression, and novel gray relational analysis to assess cost determinants and structural shifts.
- Examined factors including medical insurance, patient demographics, length of stay, and specific medical fees.
Main Results:
- Total hospitalization expenses were influenced by medical insurance type, visit frequency, gender, age, length of stay, comorbidities, and discharge method.
- Out-of-pocket payments were affected by payment group, insurance type, visit frequency, gender, marital status, admission route, length of stay, and surgery level.
- Treatment fees showed the largest structural value variation, while drug fees contributed most to structural change; diagnosis and drug fees were key drivers.
Conclusions:
- The DRG payment system effectively reduces HF patient hospitalization expenses and disease burden.
- Controlling costs requires considering patient-specific factors (e.g., visits, length of stay, comorbidities) and optimizing diagnosis and drug fee management.
- DRG implementation and medical insurance policies can optimize cost structures and manage hospitalization expenses for HF patients.
Objective:
This study aimed to explore the influencing factors and structural changes in hospitalization expenses for heart failure (HF) patients under the Diagnosis-Related Group (DRG) payment system reform, providing a scientific basis for hospitals to control the hospitalization costs of HF patients.
Methods:
A total of 4,791 hospitalized HF patients from a secondary Grade-A hospital in Liuzhou City between January 1, 2015, and July 31, 2025, were selected as the study subjects. Factors such as the timing of DRG implementation were grouped and included in the analysis. Univariate analysis and multiple linear regression were employed to analyze the influencing factors of total hospitalization expenses and out-of-pocket payments. The degree of structural change and novel gray relational analysis were used to examine the trends and correlations in the structure of hospitalization expenses for HF patients.
Results:
The total hospitalization expenses of HF patients were mainly influenced by the type of medical insurance, number of visits, gender, age, length of stay, number of other diagnosed diseases, diabetes, surgery level, and discharge method (P < 0.05). Out-of-pocket payments were primarily affected by the payment method group, type of medical insurance, number of visits, gender, marital status, admission route, length of stay, and surgery level (P < 0.05). From 2015 to 2025, the treatment fee had the largest Variation of Structural Value (VSV) at 0.1663, showing a positive change, while the drug fee contributed the most to the structural change at 34.06%. The novel gray relational analysis indicated that the top two associated items were diagnosis fees (0.8797) and drug fees (0.7647), meaning that treatment, diagnosis, and drug fees were the main factors affecting the structural changes in hospitalization expenses.
Conclusion:
The DRG payment system can effectively reduce the hospitalization expenses of HF patients, alleviating their disease burden. When controlling costs under the DRG payment system, comprehensive consideration should be given to influencing factors such as the patient's number of visits, length of stay, surgery level, gender, age, and number of other diagnosed diseases to effectively reduce hospitalization expenses. By utilizing DRG payments and medical insurance policies to manage and control diagnosis and drug fees of heart failure, hospitalization costs can be controlled, and the cost structure optimized.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
01:30Health Information Technology and Healthcare Information System
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:17Pathophysiology of Heart Failure
01:27Heart Failure I: Introduction
01:30Heart Failure V: Medical Management